- A low dose of LSD (26μg) produced more significant positive mood and stimulant-like effects in participants with mild depression compared to non-depressed controls.
- Self-reported measures indicated that participants with higher depression scores experienced a noticeable reduction in depression symptoms 48 hours after administration of LSD.
- The study highlighted the potential therapeutic effects of low-dose LSD for depression, suggesting that it may alter mood and consciousness differently in mildly depressed individuals than in those without depression.
Introduction
Depression is a common mental health disorder that can significantly impair an individual’s quality of life. Many individuals do not respond well to traditional treatment methods. Recent research has explored the potential of psychedelic substances, like LSD, as novel therapeutic options. These compounds may facilitate mood improvement and cognitive enhancement with minimal side effects when used responsibly and in low doses.
Study Design
The researchers conducted a controlled study involving 39 participants, divided based on their scores on the Beck Depression Inventory-II (BDI-II). Participants with a score of 17 or higher were categorized as mildly depressed, while those with scores below this threshold were considered non-depressed controls. Each participant experienced both a low dose of LSD and a placebo in a randomized, double-blind, crossover trial. The comparison centered on the subjective and physiological effects observed throughout the sessions, highlighting both immediate and longer-term impacts on mood.
Results Overview
Subjective Effects
During the study, participants who were given LSD consistently reported heightened “feel drug” effects, indicating a preference for the drug’s impact over placebo. Notably, participants in the high BDI group expressed stronger feelings of energy and positivity. Subjective self-reports indicated they faced higher anxiety, confusion, and fatigue, yet experienced increases in elation and energy post-LSD compared to their baseline measurements.
Physiological Measures
The researchers measured the plasma levels of LSD, which were consistent across both groups and did not correlate with subjective ratings of drug effects. Additionally, those with higher BDI scores viewed happy stimuli less positively than the low BDI group. However, LSD administration did cause an increase in positive responses towards happy faces, although it did not affect the arousal levels associated with these stimuli.
Discussion
Findings illustrated that individuals experiencing depressive symptoms exhibited more pronounced positive mood enhancements following LSD ingestion compared to non-depressed individuals. This suggests the intricacies of LSD’s effects may vary significantly based on pre-existing mental states, potentially leading to better treatment outcomes in certain populations. Two days post-session, the high BDI group recorded reduced depression scores, indicating lasting effects that warrant further exploration of LSD as a possible treatment route.
Although productivity-related cognitive functions, such as creativity, were not positively influenced by low doses of LSD, there remains a complex relationship between subjective experiences and cognitive alterations. The researchers acknowledged the need for further investigations, particularly with larger participant pools and varying levels of depression severity, to validate these preliminary findings.
Read the full paper summary on Blossom.
